About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 435387, 4 pages
http://dx.doi.org/10.1155/2013/435387
Clinical Study

Inhalation Anesthesia with Sevoflurane during Intravitreal Bevacizumab Injection in Infants with Retinopathy of Prematurity

1Department of Anesthesiology, Faculty of Medicine, Dicle University, 21280 Diyarbakır, Turkey
2Department of Ophthalmology, Faculty of Medicine, Dicle University, 21280 Diyarbakır, Turkey

Received 4 April 2013; Accepted 26 May 2013

Academic Editor: Tatsushi Mutoh

Copyright © 2013 Orhan Tokgöz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Royal College of Paediatrics and Child Health & Royal College of Ophthalmologists,” Retinopathy of Prematurity Guidelinehttp://www.rcophth.ac.uk/core/core_picker/download.asp?id=180&filetitle=UK+Retinopathy+of+Prematurity+Guideline+May+2008.
  2. P. A. Quiram and A. Capone Jr., “Current understanding and management of retinopathy of prematurity,” Current Opinion in Ophthalmology, vol. 18, no. 3, pp. 228–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Chen, A. Stahl, A. Hellstrom, and L. E. Smith, “Current update on retinopathy of prematurity: screening and treatment,” Current Opinion in Pediatrics, vol. 23, no. 2, pp. 173–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Quiroz-Mercado, M. A. Martinez-Castellanos, M. L. Hernandez-Rojas, N. Salazar-Teran, and R. V. P. Chan, “Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity,” Retina, vol. 28, no. 3, pp. S19–S25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sahin, M. Sahin, A. K. Cingü et al., “Intravitreal bevacizumab monotherapy in retinopathy of prematurity,” Pediatrics International, 2013. View at Publisher · View at Google Scholar
  6. K. L. Goa, S. Noble, and C. M. Spencer, “Sevoflurane in paediatric anaesthesia: a review,” Paediatric Drugs, vol. 1, no. 2, pp. 127–153, 1999. View at Scopus
  7. W. V. Good, R. J. Hardy, V. Dobson et al., “Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial,” Archives of Ophthalmology, vol. 121, no. 12, pp. 1684–1696, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. C. Harder, S. V. Baltz, J. B. Jonas, and F. C. Schlichtenbrede, “Intravitreal bevacizumab for retinopathy of prematurity,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 6, pp. 623–627, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. E. I. Eger II, “New inhaled anesthetics,” Anesthesiology, vol. 80, no. 4, pp. 906–922, 1994. View at Scopus
  10. R. Hartrey, “Anaesthesia for the laser treatment of neonates with retinopathy of prematurity,” Eye, vol. 21, no. 8, pp. 1025–1027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gismondi, C. Salati, M. L. Salvetat, M. Zeppieri, and P. Brusini, “Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure,” Journal of Glaucoma, vol. 18, no. 9, pp. 658–661, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. A. Marsh, W. O. Young, K. K. Dunaway et al., “Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity,” Annals of Pharmacotherapy, vol. 39, no. 5, pp. 829–833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. A. Mintz-Hittner and L. M. Best, “Antivascular endothelial growth factor for retinopathy of prematurity,” Current Opinion in Pediatrics, vol. 21, no. 2, pp. 182–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Kandasamy, R. Smith, I. M. R. Wright, and L. Hartley, “Pain relief for premature infants during ophthalmology assessment,” Journal of AAPOS, vol. 15, no. 3, pp. 276–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Yu, H. Sun, L. Yao, Y. Feng, and B. Yang, “Comparison of effective inspired concentration of sevoflurane in preterm infants with different postconceptual ages,” Paediatric Anaesthesia, vol. 21, no. 2, pp. 148–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D. M. Chen, V. Sundaram, A. Wilkinson, and C. K. Patel, “Variation in anaesthesia for the laser treatment of retinopathy of prematurity—a survey of ophthalmologists in the UK,” Eye, vol. 21, no. 8, pp. 1033–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Cogen, J. S. Parker, T. E. Sleep, F. J. Elsas, T. H. Metz Jr., and G. McGwin Jr., “Masked trial of topical anesthesia for retinopathy of prematurity eye examinations,” Journal of AAPOS, vol. 15, no. 1, pp. 45–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Castellanos, S. Schwartz, R. Leal, et al., “Pain assessment in premature infants treated with intravitreal antiangiogenic therapy for retinopathy of prematurity under topical anesthesia,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 2, pp. 491–494, 2012. View at Publisher · View at Google Scholar